New licensing agreement to maximize AIDS drug development
Longtime collaborators CONRAD and the Biosyn Division of Cellegy Pharmaceuticals, Inc. today announced a non-exclusive licensing agreement to research and develop Biosyn-patented microbicides for the prevention of HIV and other sexually transmitted diseases. The three microbicides covered under the agreement are in various stages of development and work under different mechanisms of act...WARF will ease stem cell licensing restrictions
are a step in the right direction, but don't go far enough to r...Musicnotes signs licensing deal with Christian music provider
Madison, Wis. - Word Music, a division of Warner Music Group based in Nashville, will supply...WARF enters licensing agreements for stem cell products
The agreements mark the beginning...Patent licensing: For enforcing companies, the rules have changed
Typically, the patent owner would do this by sending out a carefully worded letter asking that a party agree...Lucigen Corp. enters global licensing agreement
Under the agreement, Imaxio will retain the r...Ranbaxy Signs Licensing, Supply Agreement for Canadian Market
India's biggest drugmaker Ranbaxy Laboratories Ltd today said it had entered into a licensing and supply agreement with Janssen-Ortho Inc (JOI) for a generic version of Risperidone compressed tablets in the Canadian market. // The agreement was signed between Ranbaxy's wholly owned subsidiary, Ranbaxy Pharmaceuticals Canada Inc (RPCI) and Janssen-Ortho Inc (JOI), the company said in a...Doctors worried about Homeopathic licensing
The government today introduced a controversial licensing scheme. According to it, the packaging or covering on the homeopathic products// will be permitted to describe the ailments they claim to be able to cure. With the aim to bring homeopathic remedies into the area of licensed medicines, the National Rules System was designed. However, doctors and scientists believe that products wi...Merck Announces Plans for Licensing Atripla Widely in Developing World
Merck & Co is seeking to register its three-in-one fixed dose combination Atripla in 66 developing countries, in addition to seeking// World Health Organization prequalification for the product, the company announced on Friday. Atripla, which is a single tablet containing a daily dose of efavirenz, tenofovir and emtricitabine, will be priced at $613 a year for least developed countri...PSivida, Pfizer Ink $165 Million Licensing Pact
Perth-based bio-nanotech major, pSivida Limited has signed an exclusive worldwide Collaborative Research and License Agreement with Pfizer for its controlled// drug delivery technologies, including the Medidur technology in ophthalmic applications. Under the terms of the agreement, pSivida will receive up to $155 million in development and sales related milestones. Pfizer...Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt
Abbott Laboratories said this week that it is willing to proceed with the registration of a heat stable version of lopinavir/ritonavir called Aluvia in Thailand if the Thai// government will halt its plans for a compulsory license to allow imports of a generic version from India, and will sell it to the Thai government for $1000 a year. Abbott has been in dispute with the Thai govern...